Acromegaly and Gigantism - Epidemiology Forecast to 2023 - Risk Factors, Pathophysiology, Diagnosis & Treatment - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Acromegaly and Gigantism - Epidemiology Forecast to 2023" report to their offering.

Acromegaly is a rare but serious hormonal disorder caused by excessive growth hormone (GH) in the blood in adults. Acromegaly in adults occurs mainly in middle-aged men and women. In This condition, the bones increase in size, including those of the hands, feet and face. Acromegaly is uncommon and physical changes occur gradually thus the condition often isn't recognized immediately and if not treated promptly, it can lead to serious illness and even become life-threatening. According to research estimates, the prevalent cases of Acromegaly in the 7MM are expected to increase with a CAGR of 0.72% for the forecast period.

Gigantism is excessive production of GH in children which is extremely rare and leads to exaggerated bone growth and an abnormal increase in height. It results from high linear growth due to excessive action of insulin like growth factor I (IGF-I) while the epiphyseal growth plates are open during childhood. Acromegaly is the same disorder of IGF-I excess but occurs after the growth plate cartilage fuses in adulthood. According to research estimates, prevalent cases of Gigantism in the 6 MM are expected to increase with a CAGR of 2% and Acromegaly in the 7MM are expected to increase with a CAGR of 0.72% for the forecast period.

Key Coverage and Benefits:

  • The report will help in developing business strategies by understanding the trends shaping and driving the global epidemiology of Acromegaly and Gigantism.
  • Identifying prevalent patient populations as well as risk factors in the global Acromegaly and Gigantism market will help to improve product design, pricing, and launch plans.

Key Topics Covered:

  • Report Introduction
  • Acromegaly and Gigantism: Overview
  • Causes
  • Signs and Symptoms
  • Risk Factors
  • Pathophysiology
  • Diagnosis
  • Treatment
  • Epidemiology of Acromegaly in 7MM
  • Epidemiology and Patient Population
  • Assumptions and Caveats
  • Prevalent Population of Acromegaly in 7MM
  • Regions
  • Epidemiology of Gigantism in 6MM
  • Epidemiology and Patient Population
  • Prevalent Population of Gigantism in 6MM
  • Appendix
  • Report Methodology

For more information about this report visit http://www.researchandmarkets.com/research/8q3hr3/acromegaly_and

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Endocrine and Metabolic Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Endocrine and Metabolic Disorders Drugs